Bioavailability Enhancement of Paclitaxel via a Novel Oral Drug Delivery System: Paclitaxel-Loaded Glycyrrhizic Acid Micelles

We firstly investigated the interactions between PTX and glycyrrhizic acid and designed a nano-sized formulation that could largely increase the solubility of PTX using GA, a hypotoxic or even therapeutic material, as a carrier

Fu-Heng Yang


Scholarcy highlights

  • Paclitaxel is a natural terpenoid compound, extracted from the bark of Western Taxus brevifolia, that has excellent antitumor activities against a wide range of solid tumors, including refractory human ovarian, breast cancers and non-small-cell lung carcinoma
  • The data obtained from this study indicated that the PTX-loaded glycyrrhizic acid micelles led to a 6-fold enhancement in the oral bioavailability of PTX
  • On account of the amphiphilic characteristics of GA, the combination could form micelles in aqueous medium to enhance the solubility of PTX
  • In vitro release study showed that PTX-loaded GA micelles could be considered as a delayed drug release system
  • Compared with Taxol®, PTX-loaded GA micelles demonstrated a notable improvement of oral bioavailability in vivo, which could be largely due to the enhancement of the PTX absorption in jejunum and colon intestine
  • The encapsulation efficiency was about 90%, and the drug loading rate could reach up to 7.90%
  • The increased absorption of PTX may be attributed to a comprehensive effect of GA on the following aspects: the enhancement of PTX solubility, the nanosize drug delivery system, the inhibition of P-gp efflux and the inhibition on CYP3A
  • Unlike many other new dosage forms of PTX, of which various materials are still a long way to go to verify their clinical use, glycyrrhizic acid could be a very promising carrier for the oral delivery system of PTX, since GA itself has been used in clinic for years

Need more features? Save interactive summary cards to your Scholarcy Library.